• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Ashleigh Furlong

Stay informed with Ashleigh Furlong’s coverage and analysis for Fortune.

  • Pascal Soriot, chief executive officer of AstraZeneca Plc, speaks during a news conference at the AstraZeneca research and development hub in Mississauga, Ontario, Canada, on Monday, Feb. 27, 2023. AstraZeneca announced a $500-million investment in Canada and that it plans to add 500 new jobs at its Mississauga facility. Photographer: Cole Burston/Bloomberg via Getty ImagesTech

    AstraZeneca to buy cell therapy biotech for up to $1 billion

    By Ashleigh Furlong and Bloomberg
  • GENEVA, SWITZERLAND – JANUARY 23: The headquarters of the World Health Organization (WHO) stands on January 23, 2025 in Geneva, Switzerland. U.S. President Donald Trump has announced he will seek to withdraw the U.S. from the WHO, claiming the U.S. pays disproportionately too much into the institution. The WHO, which is a part of the United Nations and has 194 member states, is the world’s biggest intergovernmental organization tasked with public health. It plays an especially crucial role in coordinating and implementing responses to outbreaks of epidemic diseases. (Photo by Robert Hradil/Getty Images)Health

    WHO offers early retirement to cut costs ahead of U.S. exit

    By Bloomberg, Ashleigh Furlong, and others
  • Paul Hudson, chief executive officer of Sanofi SA, during a panel session on day two of the World Economic Forum (WEF) in Davos, Switzerland, on Wednesday, Jan. 17, 2024. The annual Davos gathering of political leaders, top executives and celebrities runs from January 15 to 19. Photographer: Hollie Adams/Bloomberg via Getty ImagesFinance

    Sanofi profit lifted by early vaccine sales, dupixent growth

    By Ashleigh Furlong, Tim Loh, and others
  • balding headHealth

    Hair loss drug probed in Europe over link to suicidal thoughts

    By Ashleigh Furlong and Bloomberg
  • Zantac heartburn medicine are seen at a store in Mountain View, CaliforniaRetail

    Victory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit, but thousands still to come

    By Jef Feeley, Ashleigh Furlong, and others
  • Emma Walmsley attends the 10th Annual Breakthrough Prize Awards and Ceremony at the Academy Museum of Motion Pictures in Los Angeles, California, United StatesHealth

    How GSK CEO Emma Walmsley kept her job and turned a belligerent activist investor into an ally

    By Ashleigh Furlong, Sabah Meddings, and others
  • Pascal Soriot, chief executive officer of AstraZeneca Plc.Retail

    AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030

    By Ashleigh Furlong and Bloomberg
  • woman measures her waistHealth

    Weaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says

    By Ashleigh Furlong and Bloomberg
  • Pascal Soriot, CEO of AstraZeneca. Under Soriot, Astra has invested heavily in cancer drugs.Retail

    AstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs

    By Ashleigh Furlong and Bloomberg
  • A person using OzempicRetail

    Wegovy and Ozempic have ignited a gold rush in pharma as well as an upsurge in fake ‘skinny jabs’, leading to surge in hospitalizations

    By Ashleigh Furlong and Bloomberg
    Rankings
    • 100 Best Companies
    • Fortune 500
    • Global 500
    • Fortune 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Fortune Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Fortune Brand Studio
    • Fortune Analytics
    • Fortune Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Fortune
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.